﻿<br />
<b>Warning</b>:  Undefined array key "p" in <b>/home/asialyst/www/releases/20250606081313/fr/wp-content/themes/asialyst_v2.3/shortcodes/article-category.php</b> on line <b>9</b><br />
{"id":53052,"date":"2021-07-30T07:28:52","date_gmt":"2021-07-30T05:28:52","guid":{"rendered":"https:\/\/asialyst.com\/fr\/2021\/07\/28\/brouillon-regard-exemplaire-copy-2-copy-copy-copy\/"},"modified":"2021-07-30T17:07:44","modified_gmt":"2021-07-30T15:07:44","slug":"covid-19-chine-incertitudes-immunite-collective","status":"publish","type":"post","link":"https:\/\/asialyst.com\/fr\/2021\/07\/30\/covid-19-chine-incertitudes-immunite-collective\/","title":{"rendered":"Covid-19 en Chine : les incertitudes de l\u2019immunit\u00e9 collective"},"content":{"rendered":"<div class=\"container\">\n\t<meta itemprop=\"keywords\" content=\"Soci\u00e9t\u00e9\" \/>\n\t<a href=\"https:\/\/asialyst.com\/fr\/societe\/\" class=\"category category-2\">Soci\u00e9t\u00e9<\/a><br \/>\n\t<time datetime=\"2021-07-30T07:28:52Z\" itemprop=\"datePublished\">\n\t\tPubli\u00e9 30 Juillet 2021<br \/>\n\t\tMis \u00e0 jour 30 Juillet 2021\t<\/time>\n\t<meta itemprop=\"dateModified\" content=\"2021-07-30T17:07:44Z\" \/>\n<\/div>\n<div class=\"container\">\n<div class=\"surtitre\" itemprop=\"headline\">Analyse<\/div><\/div>\n<div class=\"container\">\n\t<h1 itemprop=\"name\">Covid-19 en Chine : les incertitudes de l\u2019immunit\u00e9 collective<\/h1>\n<\/div>\n<div class=\"container\">\n  <div class=\"authors\">\n    <ul>\n    \t        <li class=\"author\" itemprop=\"author\" itemscope itemtype=\"http:\/\/schema.org\/Person\">\n          <a href=\"https:\/\/asialyst.com\/fr\/auteur\/hubert-testard\/\" class=\"category-color\" itemprop=\"url\">\n            <span itemprop=\"name\" class=\"name\">\n              Hubert Testard            <\/span>\n            <img data-del=\"avatar\" alt=\"Hubert Testard\" src='https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2022\/12\/hubert-testard.jpg' class='avatar pp-user-avatar avatar-150 photo ' height='150' width='150'\/>          <\/a>\n        <\/li>\n    \t    <\/ul>\n  <\/div>\n<\/div>\n<div class=\"container\">\n  <div class=\"photo-une\" itemprop=\"image\" itemscope itemtype=\"http:\/\/schema.org\/ImageObject\">\n    <figure>\n      <a href=\"https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/07\/chine-vaccination-immunite-collective.jpg\" class=\"article-image\" title=\"Vaccination de lyc\u00e9ens dans le district de Qianjiang \u00e0 Chongqing. Photograph: Sipa Asia\/Rex\/Shutterstock (Source : Guardian)\"><img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"900\" src=\"https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/07\/chine-vaccination-immunite-collective.jpg\" class=\"img-responsive\" alt=\"Vaccination de lyc\u00e9ens dans le district de Qianjiang \u00e0 Chongqing. Photograph: Sipa Asia\/Rex\/Shutterstock (Source : Guardian)\" srcset=\"https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/07\/chine-vaccination-immunite-collective.jpg 1200w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/07\/chine-vaccination-immunite-collective-250x188.jpg 250w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/07\/chine-vaccination-immunite-collective-1024x768.jpg 1024w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/07\/chine-vaccination-immunite-collective-150x113.jpg 150w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/07\/chine-vaccination-immunite-collective-768x576.jpg 768w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/07\/chine-vaccination-immunite-collective-200x150.jpg 200w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/07\/chine-vaccination-immunite-collective-267x200.jpg 267w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/07\/chine-vaccination-immunite-collective-533x400.jpg 533w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/07\/chine-vaccination-immunite-collective-800x600.jpg 800w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/07\/chine-vaccination-immunite-collective-1137x853.jpg 1137w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/07\/chine-vaccination-immunite-collective-680x510.jpg 680w\" sizes=\"auto, (max-width: 1200px) 100vw, 1200px\" \/><\/a>\n      <meta itemprop=\"height\" content=\"1200\"\/>\n      <meta itemprop=\"width\" content=\"900\"\/>\n      <meta itemprop=\"contentUrl\" content=\"https:\/\/asialyst.com\/fr\/2021\/07\/30\/covid-19-chine-incertitudes-immunite-collective\/\"\/>\n      <figcaption class=\"legend\" itemprop=\"description\">\n      \t<div class=\"container\">\n        \tVaccination de lyc\u00e9ens dans le district de Qianjiang \u00e0 Chongqing. Photograph: Sipa Asia\/Rex\/Shutterstock (Source : <a href=\"https:\/\/www.theguardian.com\/society\/2021\/jun\/15\/china-set-to-deliver-1bn-covid-vaccine-doses-by-end-of-this-week\" rel=\"noopener\" target=\"_blank\">Guardian<\/a>)        <\/div>\n      <\/figcaption>\n    <\/figure>\n  <\/div>\n<\/div>\n\n<div class=\"container\">\n\t<div class=\"chapo\" itemprop=\"description\">\n\t\tLa Chine a d\u00e9sormais les capacit\u00e9s industrielles n\u00e9cessaires pour vacciner l\u2019ensemble de sa population. Avec 100 millions de doses par semaine, son programme massif de vaccination lui permettrait, en principe, d\u2019atteindre le seuil d\u2019immunit\u00e9 collective \u00e0 l\u2019automne. Mais les experts chinois multiplient les avertissements sur l\u2019efficacit\u00e9 de leurs vaccins. Les d\u00e9bats se d\u00e9veloppent sur l\u2019id\u00e9e d\u2019un mixage de vaccins et d\u2019une troisi\u00e8me dose. De son c\u00f4t\u00e9, le gouvernement freine les initiatives de vaccination obligatoire men\u00e9es par certaines provinces face aux r\u00e9ticences d\u2019une minorit\u00e9 de la population chinoise. L\u2019horizon de l\u2019immunit\u00e9 collective s\u2019\u00e9loigne.\t<\/div>\n<\/div>\n<div class=\"container\">\n\t<div class=\"text\" itemprop=\"articleBody\">\n\t\tLa Chine s\u2019est efficacement isol\u00e9e contre les r\u00e9surgences du Covid-19 sur son territoire et m\u00e8ne un programme de vaccination de tr\u00e8s grande ampleur. Elle est en th\u00e9orie capable de devenir un des premiers pays immunis\u00e9s au monde. Et pourtant, les experts chinois se pr\u00e9parent \u00e0 la poursuite d\u2019une bataille de longue haleine.\t<\/div>\n<\/div>\n\n<div class=\"container\">\n\t<h2>Capacit\u00e9s industrielles et administratives pour immuniser la population \u00e0 l\u2019automne<\/h2>\n<\/div>\n<div class=\"container\">\n\t<div class=\"text\" itemprop=\"articleBody\">\n\t\tLe 9 juillet dernier, le minist\u00e8re chinois de l\u2019Industrie annon\u00e7ait que son pays disposait d\u2019une capacit\u00e9 de production globale de cinq milliards de doses de vaccins contre le Covid-19 pour 2021. Ce qui est suffisant pour fournir \u00e0 la fois la population chinoise et la quarantaine de pays avec lesquels la Chine a sign\u00e9 des accords de distribution.\t<\/div>\n<\/div>\n\n<div class=\"container\">\n\t<div class=\"text\" itemprop=\"articleBody\">\n\t\tLe rythme de diffusion des vaccins se situe par ailleurs depuis mai autour de 100 millions de doses par semaine. Le nombre de vaccins distribu\u00e9s a atteint 1,5 milliards de doses le 24 juillet, et l\u2019objectif officiel consistant \u00e0 vacciner compl\u00e8tement 70 % de la population chinoise peut \u00eatre atteint avant fin octobre au rythme actuel du programme de vaccination.\t<\/div>\n<\/div>\n\n<div class=\"container\">\n\t<div class=\"text\" itemprop=\"articleBody\">\n\t\tParall\u00e8lement, le syst\u00e8me tr\u00e8s strict de contr\u00f4le et d\u2019\u00e9limination des nouveaux clusters maintient le nombre de cas \u00e0 quelques dizaines par jour. Le pays n\u2019a d\u00e9clar\u00e9 aucun mort du coronavirus depuis fin avril 2020, pla\u00e7ant la Chine \u00e0 l\u2019\u00e9cart des nouvelles vagues asiatiques. Autant d\u2019\u00e9l\u00e9ments qui pourraient rendre le gouvernement chinois particuli\u00e8rement optimiste sur sa capacit\u00e9 \u00e0 \u00e9radiquer la pand\u00e9mie de son territoire, ce qui n\u2019est pas le cas.\t<\/div>\n<\/div>\n\n<div class=\"container\">\n\t<h2>Prudence et nouvelles recommandations des experts chinois<\/h2>\n<\/div>\n<div class=\"container\">\n\t<div class=\"text\" itemprop=\"articleBody\">\n\t\tGao Fu, le patron du centre chinois de contr\u00f4le des \u00e9pid\u00e9mies, avait indiqu\u00e9 le 12 avril dernier en conf\u00e9rence de presse que les vaccins chinois avaient une efficacit\u00e9 insuffisante. Cette d\u00e9claration a fait beaucoup de bruit dans la presse internationale, ce qui a conduit Gao par la suite \u00e0 assur\u00e9 que ses propos avaient \u00e9t\u00e9 <em>\u00ab\u00a0mal interpr\u00e9t\u00e9s\u00a0\u00bb. <\/em>Gao Fu \u00e9voquait par ailleurs l\u2019utilit\u00e9 de mixer diff\u00e9rents vaccins et de r\u00e9fl\u00e9chir aux d\u00e9lais entre les doses de vaccins.\t<\/div>\n<\/div>\n\n<div class=\"container\">\n\t<div class=\"text\" itemprop=\"articleBody\">\n\t\tDeux mois plus tard, le docteur Feng Zijian, ancien directeur adjoint du centre chinois de contr\u00f4le des \u00e9pid\u00e9mies, admettait que les anticorps cr\u00e9\u00e9s par les vaccins chinois \u00e9taient moins efficaces contre le variant Delta.\t<\/div>\n<\/div>\n\n<div class=\"container\">\n\t<div class=\"text\" itemprop=\"articleBody\">\n\t\tUn autre expert reconnu, le professeur Guan Yi, responsable du centre d\u2019\u00e9tude des \u00e9pid\u00e9mies de l\u2019Universit\u00e9 de Hong Kong, expliquait dans un long interview \u00e0 la cha\u00eene de t\u00e9l\u00e9vision Phoenix que l\u2019efficacit\u00e9 des vaccins est un concept transitoire. M\u00eame si elle peut \u00eatre d\u00e9montr\u00e9e initialement, elle peut diminuer de moiti\u00e9 dans les six mois et dispara\u00eetre au bout d\u2019un an. Le docteur Guan Yi estimait indispensable que la Chine se dote d\u2019un dispositif plus structur\u00e9 d\u2019analyse des nouveaux variants et poursuive une recherche permanente pour l\u2019adaptation des vaccins.\t<\/div>\n<\/div>\n\n<div class=\"container\">\n\t<div class=\"text\" itemprop=\"articleBody\">\n\t\tGao Fu lui-m\u00eame annon\u00e7ait sur CCTV le 21 juillet qu\u2019il avait pris une troisi\u00e8me dose de vaccin. Cette solution de la troisi\u00e8me dose fait l\u2019objet d\u2019\u00e9tudes cliniques depuis le mois de mai dans la province du Jiangsu et pourrait devenir la norme dans les prochains mois.\t<\/div>\n<\/div>\n\n<div class=\"container\">\n\t<div class=\"text\" itemprop=\"articleBody\">\n\t\tPar ailleurs la Chine s\u2019int\u00e9resse de plus en plus aux vaccins \u00e0 base d\u2019ARN messager. Fosun a sign\u00e9 avec l\u2019aval du gouvernement chinois un accord de sous-traitance avec Pfizer-Biontech pour la diffusion de leur vaccin en Chine. La firme de Shanghai vient d\u2019annoncer que la production de ce vaccin pourrait atteindre un milliard de doses sur le territoire chinois d\u2019ici la fin de l\u2019ann\u00e9e, au rythme de 100, puis 200 millions de doses par mois. Selon le media chinois <em>Caixin, <\/em>ce vaccin servirait de troisi\u00e8me dose pour les citoyens chinois qui ont d\u00e9j\u00e0 re\u00e7u deux doses de vaccins chinois. L\u2019Universit\u00e9 de Hong Kong m\u00e8ne actuellement des \u00e9tudes cliniques sur le mixage des vaccins chinois et de ceux \u00e0 base d\u2019ARN messager.\t<\/div>\n<\/div>\n\n<div class=\"container\">\n\t<div class=\"text\" itemprop=\"articleBody\">\n\t\tPar ailleurs, les essais cliniques de phase trois du premier vaccin chinois \u00e0 base d\u2019ARN messager ont commenc\u00e9 depuis le mois d\u2019avril 2021. Il s\u2019agit d\u2019un vaccin d\u00e9velopp\u00e9 conjointement par Abogenbio, Walwax Biotechnologies et l\u2019Institut de m\u00e9decine militaire de l\u2019Acad\u00e9mie chinoise des sciences. Si ces essais sont concluants, une mise sur le march\u00e9 de ce vaccin est envisageable avant la fin de l\u2019ann\u00e9e.\t<\/div>\n<\/div>\n\n<div class=\"container\">\n\t<h2>H\u00e9sitation sur la vaccination obligatoire<\/h2>\n<\/div>\n<div class=\"container\">\n\t<div class=\"text\" itemprop=\"articleBody\">\n\t\tLa recherche de l\u2019immunit\u00e9 collective a pouss\u00e9 ces derni\u00e8res semaines un certain nombre de provinces et de villes chinoises \u00e0 cr\u00e9er des sanctions pour les retardataires. Le  Guangxi et le Henan ont par exemple annonc\u00e9 qu\u2019elles n\u2019accepteraient lors de la prochaine rentr\u00e9e scolaire de septembre que les enfants dont les familles sont vaccin\u00e9es. D\u2019autres r\u00e9gions ont commenc\u00e9 \u00e0 imposer la vaccination pour l\u2019acc\u00e8s aux lieux publics, aux restaurants et aux commerces. Le comt\u00e9 de Tanghe dans la province du Henan est all\u00e9 jusqu\u2019\u00e0 menacer les fonctionnaires et les retrait\u00e9s de la fonction publique de ne plus leur verser de salaire ou de pension s\u2019ils n\u2019\u00e9taient pas vaccin\u00e9s.\t<\/div>\n<\/div>\n\n<div class=\"container\">\n\t<div class=\"text\" itemprop=\"articleBody\">\n\t\tCes diff\u00e9rentes initiatives ont soulev\u00e9 de nombreuses critiques sur les r\u00e9seaux sociaux chinois. Elles ont \u00e9t\u00e9 stopp\u00e9es par le gouvernement, qui ne souhaite pas \u00e0 ce stade cr\u00e9er de pol\u00e9mique inutile. Les autorit\u00e9s sanitaires chinoises ont d\u00e9clar\u00e9 que la vaccination devait \u00eatre <em>\u00ab\u00a0inform\u00e9e, consentie et volontaire\u00a0\u00bb. <\/em>Il est vrai que les r\u00e9ticences \u00e0 l\u2019\u00e9gard de la vaccination sont beaucoup moins fortes en Chine qu\u2019en France si l\u2019on en croit les sondages r\u00e9guliers faits pour le compte du World Economic Forum par la soci\u00e9t\u00e9 Ipsos. Dans cinq sondages comparatifs r\u00e9alis\u00e9s entre juillet 2020 et avril 2021, la proportion de citoyens chinois qui souhaitent se faire vacciner reste stable, autour de 80 %, alors que celle des Fran\u00e7ais est de l\u2019ordre de 60 %.\t<\/div>\n<\/div>\n\n<div class=\"container\">\n\t<div class=\"text\" itemprop=\"articleBody\">\n\t\tAu total, le gouvernement chinois se pr\u00e9pare \u00e0 une bataille prolong\u00e9e contre le coronavirus, o\u00f9 l\u2019efficacit\u00e9 d\u00e9croissante des vaccins actuels doit \u00eatre compens\u00e9e par de nouvelles doses, des mixages, de nouveaux vaccins, et o\u00f9 la recherche de l\u2019immunit\u00e9 collective ne doit pas \u00eatre pr\u00e9cipit\u00e9e au d\u00e9triment de la coh\u00e9sion nationale.\t<\/div>\n<\/div>\n\n<div class=\"container\">\n\t<div class=\"text\" itemprop=\"articleBody\">\n\t\t<strong>Par Hubert Testard<\/strong>\t<\/div>\n<\/div>\n\n<div class=\"container\">\n\t<div class=\"text\" style=\"background:#d9463d; padding:20px 20px 30px 20px; text-align:center; border-radius:8px;\">\n\t\t<h3 style=\"color:#fff; font-weight:700;\">Soutenez-nous !<\/h3>\n\t\t<p style=\"color:#fff; font-size:0.8em; line-height:1.5em; margin-bottom:30px;\">Asialyst est con\u00e7u par une \u00e9quipe compos\u00e9e \u00e0 100 % de b\u00e9n\u00e9voles et gr\u00e2ce \u00e0 un r\u00e9seau de contributeurs en Asie ou ailleurs, journalistes, experts, universitaires, consultants ou anciens diplomates... Notre seul but : partager la connaissance de l'Asie au plus large public.<\/p>\n\t\t<a href=\"https:\/\/www.helloasso.com\/associations\/les-amis-d-asialyst\/formulaires\/1\" target=\"_blank\" style=\"display:inline; background:#fff; padding:10px 25px; font-weight:700; border-radius:4px; color:#000; font-size:0.9em;\">Faire un don<\/a>\n\t<\/div>\n<\/div>\n<div class=\"container\">\n\t<div class=\"tags\">\n\t\t<h5>Tags de l'article<\/h5>\n\t\t<ul><li><a href=\"https:\/\/asialyst.com\/fr\/tag\/asie-du-nord-est\/\" rel=\"tag\">Asie du Nord-Est<\/a><\/li><li><a href=\"https:\/\/asialyst.com\/fr\/tag\/chine\/\" rel=\"tag\">Chine<\/a><\/li><li><a href=\"https:\/\/asialyst.com\/fr\/tag\/coronavirus\/\" rel=\"tag\">coronavirus<\/a><\/li><li><a href=\"https:\/\/asialyst.com\/fr\/tag\/covid-19\/\" rel=\"tag\">covid-19<\/a><\/li><li><a href=\"https:\/\/asialyst.com\/fr\/tag\/epidemie\/\" rel=\"tag\">\u00e9pid\u00e9mie<\/a><\/li><li><a href=\"https:\/\/asialyst.com\/fr\/tag\/pandemie\/\" rel=\"tag\">pand\u00e9mie<\/a><\/li><li><a href=\"https:\/\/asialyst.com\/fr\/tag\/vaccin\/\" rel=\"tag\">vaccin<\/a><\/li><li><a href=\"https:\/\/asialyst.com\/fr\/tag\/vaccination\/\" rel=\"tag\">vaccination<\/a><\/li><\/ul><ul>\t<\/ul><\/div>\n<\/div>\n\n\t\t<div class=\"social-sharing ss-social-sharing\">\r\n\t\t\t\t        <a onclick=\"return ss_plugin_loadpopup_js(this);\" rel=\"external nofollow\" class=\"ss-button-facebook\" href=\"http:\/\/www.facebook.com\/sharer\/sharer.php?u=https%3A%2F%2Fasialyst.com%2Ffr%2F2021%2F07%2F30%2Fcovid-19-chine-incertitudes-immunite-collective%2F\" target=\"_blank\">Share on Facebook<\/a><a onclick=\"return ss_plugin_loadpopup_js(this);\" rel=\"external nofollow\" class=\"ss-button-twitter\" href=\"http:\/\/twitter.com\/intent\/tweet\/?text=Covid-19+en+Chine+%3A+les+incertitudes+de+l%E2%80%99immunit%C3%A9+collective&url=https%3A%2F%2Fasialyst.com%2Ffr%2F2021%2F07%2F30%2Fcovid-19-chine-incertitudes-immunite-collective%2F&via=asialyst\" target=\"_blank\">Share on Twitter<\/a><a onclick=\"return ss_plugin_loadpopup_js(this);\" rel=\"external nofollow\" class=\"ss-button-linkedin\" href=\"http:\/\/www.linkedin.com\/shareArticle?mini=true&url=https%3A%2F%2Fasialyst.com%2Ffr%2F2021%2F07%2F30%2Fcovid-19-chine-incertitudes-immunite-collective%2F&title=Covid-19+en+Chine+%3A+les+incertitudes+de+l%E2%80%99immunit%C3%A9+collective\" target=\"_blank\">Share on Linkedin<\/a><a onclick=\"return ss_plugin_loadpopup_js(this);\" rel=\"external nofollow\" class=\"ss-button-pinterest\" href=\"http:\/\/pinterest.com\/pin\/create\/button\/?url=https%3A%2F%2Fasialyst.com%2Ffr%2F2021%2F07%2F30%2Fcovid-19-chine-incertitudes-immunite-collective%2F&media=https%3A%2F%2Fasialyst.com%2Ffr%2Fwp-content%2Fuploads%2F2021%2F07%2Fchine-vaccination-immunite-collective-250x188.jpg&description=Covid-19+en+Chine+%3A+les+incertitudes+de+l%E2%80%99immunit%C3%A9+collective\" target=\"_blank\">Share on Pinterest<\/a>\t        \t    <\/div>\r\n\t    \n<div class=\"container\">\n\t<div class=\"auteurs-a-propos\">\n\t\t<h5>A propos de l'auteur<\/h5>\n\t\t\t\t\t<div class=\"author\">\n\t\t\t\t<img data-del=\"avatar\" src='https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2022\/12\/hubert-testard.jpg' class='avatar pp-user-avatar avatar-150wp-user-avatar wp-user-avatar-150 photo ' height='150' width='150'\/>\t\t\t\t<div class=\"infos\">\n\t\t\t\t\t<div class=\"name\">\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/asialyst.com\/fr\/auteur\/hubert-testard\/\">\n\t\t\t\t\t\t\tHubert Testard\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<div class=\"description\">\n\t\t\t\t\t\tHubert Testard est un sp\u00e9cialiste de l\u2019Asie et des enjeux \u00e9conomiques internationaux. Il a \u00e9t\u00e9 conseiller \u00e9conomique et financier pendant 20 ans dans les ambassades de France au Japon, en Chine, en Cor\u00e9e et \u00e0 Singapour pour l\u2019Asean. Il a \u00e9galement particip\u00e9 \u00e0 l\u2019\u00e9laboration des politiques europ\u00e9ennes et en particulier de la politique commerciale, qu\u2019il s\u2019agisse de l\u2019OMC ou des n\u00e9gociations avec les pays d\u2019Asie. Il enseigne depuis onze ans au coll\u00e8ge des affaires internationales de Sciences Po sur l\u2019analyse prospective de l\u2019Asie. Il est l\u2019auteur d\u2019un livre intitul\u00e9 \"Pand\u00e9mie, le basculement du monde\", paru en mars 2021 aux \u00e9ditions de l\u2019Aube, et il a contribu\u00e9 en octobre 2022 \u00e0 un ouvrage collectif intitul\u00e9 \"Le dossier chinois\" aux \u00e9ditions Le Cherche-Midi.\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t<\/div>\n<\/div>\n<div class=\"block3news\">\n\t<div class=\"container\">\n\t\t<div class=\"recommand\">\n\t\t\t<h5>On vous recommande<\/h5>\t\t\t<ul class=\"row\">\n\t\t\t\t<li class=\"col-md-6 col-sm-12 col-xs-12 news\"><a href=\"https:\/\/asialyst.com\/fr\/2021\/07\/21\/covid-19-vaccination-decolle-asie-mais-doutes-augmentent-vaccin-chinois\/\"><span class=\"photo\"><img loading=\"lazy\" decoding=\"async\" width=\"600\" height=\"400\" src=\"https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/07\/philippines-vaccin-centre-600x400.jpg\" class=\"img-responsive wp-post-image\" alt=\"La proportion de personnes vaccin\u00e9es reste encore en dessous de 10 % de la population aux Philippines, de m\u00eame qu&#039;en Inde, au Pakistan et en Indon\u00e9sie. (Source : NPR)\" srcset=\"https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/07\/philippines-vaccin-centre-600x400.jpg 600w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/07\/philippines-vaccin-centre-250x166.jpg 250w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/07\/philippines-vaccin-centre-1024x682.jpg 1024w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/07\/philippines-vaccin-centre-150x100.jpg 150w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/07\/philippines-vaccin-centre-768x511.jpg 768w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/07\/philippines-vaccin-centre-1536x1023.jpg 1536w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/07\/philippines-vaccin-centre-200x133.jpg 200w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/07\/philippines-vaccin-centre-300x200.jpg 300w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/07\/philippines-vaccin-centre-900x600.jpg 900w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/07\/philippines-vaccin-centre-1280x853.jpg 1280w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/07\/philippines-vaccin-centre-1600x1065.jpg 1600w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/07\/philippines-vaccin-centre-680x453.jpg 680w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/07\/philippines-vaccin-centre.jpg 1622w\" sizes=\"auto, (max-width: 600px) 100vw, 600px\" \/><\/span><span class=\"info\"><span class=\"metadata category category-\">Soci\u00e9t\u00e9<\/span><h4>Covid-19 : la vaccination d\u00e9colle en Asie mais les doutes augmentent sur les vaccins chinois<\/h4><\/span><\/a><\/li><li class=\"col-md-6 col-sm-12 col-xs-12 news\"><a href=\"https:\/\/asialyst.com\/fr\/2021\/06\/10\/covid-19-asie-pourquoi-pandemie-reprise-devrait-nous-alerter\/\"><span class=\"photo\"><img loading=\"lazy\" decoding=\"async\" width=\"600\" height=\"312\" src=\"https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/06\/thailande-bangkok-aeroport-vaccination-covid-19-1-600x312.jpg\" class=\"img-responsive wp-post-image\" alt=\"Vaccination contre le Covid-19 avec des doses de CoronaVac du laboratoire chinois Sinovac, \u00e0 l&#039;a\u00e9roport international Suvarnabhumi \u00e0 Bangkok, le 28 avril 2021. Au 31 mai, la Tha\u00eflande avait vaccin\u00e9 5,2 % de sa population. (Photo by Lillian SUWANRUMPHA \/ AFP) (Photo by LILLIAN SUWANRUMPHA\/AFP via Getty Images)\" srcset=\"https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/06\/thailande-bangkok-aeroport-vaccination-covid-19-1-600x312.jpg 600w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/06\/thailande-bangkok-aeroport-vaccination-covid-19-1-250x130.jpg 250w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/06\/thailande-bangkok-aeroport-vaccination-covid-19-1-1024x533.jpg 1024w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/06\/thailande-bangkok-aeroport-vaccination-covid-19-1-150x78.jpg 150w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/06\/thailande-bangkok-aeroport-vaccination-covid-19-1-768x400.jpg 768w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/06\/thailande-bangkok-aeroport-vaccination-covid-19-1-1536x799.jpg 1536w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/06\/thailande-bangkok-aeroport-vaccination-covid-19-1-200x104.jpg 200w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/06\/thailande-bangkok-aeroport-vaccination-covid-19-1-300x156.jpg 300w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/06\/thailande-bangkok-aeroport-vaccination-covid-19-1-900x468.jpg 900w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/06\/thailande-bangkok-aeroport-vaccination-covid-19-1-1280x666.jpg 1280w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/06\/thailande-bangkok-aeroport-vaccination-covid-19-1-1600x833.jpg 1600w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/06\/thailande-bangkok-aeroport-vaccination-covid-19-1-680x354.jpg 680w, https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/06\/thailande-bangkok-aeroport-vaccination-covid-19-1.jpg 2000w\" sizes=\"auto, (max-width: 600px) 100vw, 600px\" \/><\/span><span class=\"info\"><span class=\"metadata category category-\">Soci\u00e9t\u00e9<\/span><h4>Covid-19 en Asie : pourquoi la reprise de la pand\u00e9mie devrait nous alerter<\/h4><\/span><\/a><\/li>\t\t\t<\/ul>\n\t\t<\/div>\n\t<\/div>\n<\/div>\n<div class=\"container\">\n\t<div class=\"comments\">\n\t\t\t<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Avec 100 millions de doses par semaine, la Chine a d\u00e9sormais les capacit\u00e9s industrielles n\u00e9cessaires pour vacciner l\u2019ensemble de sa population. Ce qui lui permettrait, en principe, d\u2019atteindre le seuil d\u2019immunit\u00e9 collective \u00e0 l\u2019automne. Mais les experts chinois multiplient les avertissements sur l\u2019efficacit\u00e9 de leurs vaccins. Les d\u00e9bats se d\u00e9veloppent sur l\u2019id\u00e9e d\u2019un mixage de vaccins et d\u2019une troisi\u00e8me dose. De son c\u00f4t\u00e9, le gouvernement freine les initiatives de vaccination obligatoire men\u00e9es par certaines provinces face aux r\u00e9ticences d\u2019une minorit\u00e9 de la population chinoise. L\u2019horizon de l\u2019immunit\u00e9 collective s\u2019\u00e9loigne.<\/p>\n","protected":false},"author":277,"featured_media":53057,"comment_status":"open","ping_status":"open","sticky":true,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[23,22,1848,1877,1301,1868,1836,1913],"class_list":["post-53052","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-societe","tag-asie-du-nord-est","tag-chine","tag-coronavirus","tag-covid-19","tag-epidemie","tag-pandemie","tag-vaccin","tag-vaccination"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Covid-19 en Chine : les incertitudes de l\u2019immunit\u00e9 collective - Asialyst<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/asialyst.com\/fr\/2021\/07\/30\/covid-19-chine-incertitudes-immunite-collective\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Covid-19 en Chine : les incertitudes de l\u2019immunit\u00e9 collective - Asialyst\" \/>\n<meta property=\"og:description\" content=\"Avec 100 millions de doses par semaine, la Chine a d\u00e9sormais les capacit\u00e9s industrielles n\u00e9cessaires pour vacciner l\u2019ensemble de sa population. Ce qui lui permettrait, en principe, d\u2019atteindre le seuil d\u2019immunit\u00e9 collective \u00e0 l\u2019automne. Mais les experts chinois multiplient les avertissements sur l\u2019efficacit\u00e9 de leurs vaccins. Les d\u00e9bats se d\u00e9veloppent sur l\u2019id\u00e9e d\u2019un mixage de vaccins et d\u2019une troisi\u00e8me dose. De son c\u00f4t\u00e9, le gouvernement freine les initiatives de vaccination obligatoire men\u00e9es par certaines provinces face aux r\u00e9ticences d\u2019une minorit\u00e9 de la population chinoise. L\u2019horizon de l\u2019immunit\u00e9 collective s\u2019\u00e9loigne.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/asialyst.com\/fr\/2021\/07\/30\/covid-19-chine-incertitudes-immunite-collective\/\" \/>\n<meta property=\"og:site_name\" content=\"Asialyst\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Asialyst.fr\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-30T05:28:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-30T15:07:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/07\/chine-vaccination-immunite-collective.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Hubert Testard\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Hubert Testard\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/2021\\\/07\\\/30\\\/covid-19-chine-incertitudes-immunite-collective\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/2021\\\/07\\\/30\\\/covid-19-chine-incertitudes-immunite-collective\\\/\"},\"author\":{\"name\":\"Hubert Testard\",\"@id\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/#\\\/schema\\\/person\\\/69bfaa6a2bbb4d14c7f57c078c1b94cb\"},\"headline\":\"Covid-19 en Chine : les incertitudes de l\u2019immunit\u00e9 collective\",\"datePublished\":\"2021-07-30T05:28:52+00:00\",\"dateModified\":\"2021-07-30T15:07:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/2021\\\/07\\\/30\\\/covid-19-chine-incertitudes-immunite-collective\\\/\"},\"wordCount\":1295,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/2021\\\/07\\\/30\\\/covid-19-chine-incertitudes-immunite-collective\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/chine-vaccination-immunite-collective.jpg\",\"keywords\":[\"Asie du Nord-Est\",\"Chine\",\"coronavirus\",\"covid-19\",\"\u00e9pid\u00e9mie\",\"pand\u00e9mie\",\"vaccin\",\"vaccination\"],\"articleSection\":[\"Soci\u00e9t\u00e9\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/asialyst.com\\\/fr\\\/2021\\\/07\\\/30\\\/covid-19-chine-incertitudes-immunite-collective\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/2021\\\/07\\\/30\\\/covid-19-chine-incertitudes-immunite-collective\\\/\",\"url\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/2021\\\/07\\\/30\\\/covid-19-chine-incertitudes-immunite-collective\\\/\",\"name\":\"Covid-19 en Chine : les incertitudes de l\u2019immunit\u00e9 collective - Asialyst\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/2021\\\/07\\\/30\\\/covid-19-chine-incertitudes-immunite-collective\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/2021\\\/07\\\/30\\\/covid-19-chine-incertitudes-immunite-collective\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/chine-vaccination-immunite-collective.jpg\",\"datePublished\":\"2021-07-30T05:28:52+00:00\",\"dateModified\":\"2021-07-30T15:07:44+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/2021\\\/07\\\/30\\\/covid-19-chine-incertitudes-immunite-collective\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/asialyst.com\\\/fr\\\/2021\\\/07\\\/30\\\/covid-19-chine-incertitudes-immunite-collective\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/2021\\\/07\\\/30\\\/covid-19-chine-incertitudes-immunite-collective\\\/#primaryimage\",\"url\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/chine-vaccination-immunite-collective.jpg\",\"contentUrl\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/chine-vaccination-immunite-collective.jpg\",\"width\":1200,\"height\":900,\"caption\":\"Vaccination de lyc\u00e9ens dans le district de Qianjiang \u00e0 Chongqing. Photograph: Sipa Asia\\\/Rex\\\/Shutterstock (Source : Guardian)\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/2021\\\/07\\\/30\\\/covid-19-chine-incertitudes-immunite-collective\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Covid-19 en Chine : les incertitudes de l\u2019immunit\u00e9 collective\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/\",\"name\":\"Asialyst\",\"description\":\"Votre m\u00e9dia sur l Asie\",\"publisher\":{\"@id\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/#organization\",\"name\":\"Asialyst\",\"url\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/logo_blanc.png\",\"contentUrl\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/logo_blanc.png\",\"width\":657,\"height\":165,\"caption\":\"Asialyst\"},\"image\":{\"@id\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Asialyst.fr\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/#\\\/schema\\\/person\\\/69bfaa6a2bbb4d14c7f57c078c1b94cb\",\"name\":\"Hubert Testard\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/hubert-testard-137x150.jpg\",\"url\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/hubert-testard-137x150.jpg\",\"contentUrl\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/hubert-testard-137x150.jpg\",\"caption\":\"Hubert Testard\"},\"description\":\"Hubert Testard est un sp\u00e9cialiste de l\u2019Asie et des enjeux \u00e9conomiques internationaux. Il a \u00e9t\u00e9 conseiller \u00e9conomique et financier pendant 20 ans dans les ambassades de France au Japon, en Chine, en Cor\u00e9e et \u00e0 Singapour pour l\u2019Asean. Il a \u00e9galement particip\u00e9 \u00e0 l\u2019\u00e9laboration des politiques europ\u00e9ennes et en particulier de la politique commerciale, qu\u2019il s\u2019agisse de l\u2019OMC ou des n\u00e9gociations avec les pays d\u2019Asie. Il enseigne depuis onze ans au coll\u00e8ge des affaires internationales de Sciences Po sur l\u2019analyse prospective de l\u2019Asie. Il est l\u2019auteur d\u2019un livre intitul\u00e9 \\\"Pand\u00e9mie, le basculement du monde\\\", paru en mars 2021 aux \u00e9ditions de l\u2019Aube, et il a contribu\u00e9 en octobre 2022 \u00e0 un ouvrage collectif intitul\u00e9 \\\"Le dossier chinois\\\" aux \u00e9ditions Le Cherche-Midi.\",\"url\":\"https:\\\/\\\/asialyst.com\\\/fr\\\/auteur\\\/hubert-testard\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Covid-19 en Chine : les incertitudes de l\u2019immunit\u00e9 collective - Asialyst","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/asialyst.com\/fr\/2021\/07\/30\/covid-19-chine-incertitudes-immunite-collective\/","og_locale":"fr_FR","og_type":"article","og_title":"Covid-19 en Chine : les incertitudes de l\u2019immunit\u00e9 collective - Asialyst","og_description":"Avec 100 millions de doses par semaine, la Chine a d\u00e9sormais les capacit\u00e9s industrielles n\u00e9cessaires pour vacciner l\u2019ensemble de sa population. Ce qui lui permettrait, en principe, d\u2019atteindre le seuil d\u2019immunit\u00e9 collective \u00e0 l\u2019automne. Mais les experts chinois multiplient les avertissements sur l\u2019efficacit\u00e9 de leurs vaccins. Les d\u00e9bats se d\u00e9veloppent sur l\u2019id\u00e9e d\u2019un mixage de vaccins et d\u2019une troisi\u00e8me dose. De son c\u00f4t\u00e9, le gouvernement freine les initiatives de vaccination obligatoire men\u00e9es par certaines provinces face aux r\u00e9ticences d\u2019une minorit\u00e9 de la population chinoise. L\u2019horizon de l\u2019immunit\u00e9 collective s\u2019\u00e9loigne.","og_url":"https:\/\/asialyst.com\/fr\/2021\/07\/30\/covid-19-chine-incertitudes-immunite-collective\/","og_site_name":"Asialyst","article_publisher":"https:\/\/www.facebook.com\/Asialyst.fr","article_published_time":"2021-07-30T05:28:52+00:00","article_modified_time":"2021-07-30T15:07:44+00:00","og_image":[{"width":1200,"height":900,"url":"https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/07\/chine-vaccination-immunite-collective.jpg","type":"image\/jpeg"}],"author":"Hubert Testard","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Hubert Testard","Dur\u00e9e de lecture estim\u00e9e":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/asialyst.com\/fr\/2021\/07\/30\/covid-19-chine-incertitudes-immunite-collective\/#article","isPartOf":{"@id":"https:\/\/asialyst.com\/fr\/2021\/07\/30\/covid-19-chine-incertitudes-immunite-collective\/"},"author":{"name":"Hubert Testard","@id":"https:\/\/asialyst.com\/fr\/#\/schema\/person\/69bfaa6a2bbb4d14c7f57c078c1b94cb"},"headline":"Covid-19 en Chine : les incertitudes de l\u2019immunit\u00e9 collective","datePublished":"2021-07-30T05:28:52+00:00","dateModified":"2021-07-30T15:07:44+00:00","mainEntityOfPage":{"@id":"https:\/\/asialyst.com\/fr\/2021\/07\/30\/covid-19-chine-incertitudes-immunite-collective\/"},"wordCount":1295,"commentCount":0,"publisher":{"@id":"https:\/\/asialyst.com\/fr\/#organization"},"image":{"@id":"https:\/\/asialyst.com\/fr\/2021\/07\/30\/covid-19-chine-incertitudes-immunite-collective\/#primaryimage"},"thumbnailUrl":"https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/07\/chine-vaccination-immunite-collective.jpg","keywords":["Asie du Nord-Est","Chine","coronavirus","covid-19","\u00e9pid\u00e9mie","pand\u00e9mie","vaccin","vaccination"],"articleSection":["Soci\u00e9t\u00e9"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/asialyst.com\/fr\/2021\/07\/30\/covid-19-chine-incertitudes-immunite-collective\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/asialyst.com\/fr\/2021\/07\/30\/covid-19-chine-incertitudes-immunite-collective\/","url":"https:\/\/asialyst.com\/fr\/2021\/07\/30\/covid-19-chine-incertitudes-immunite-collective\/","name":"Covid-19 en Chine : les incertitudes de l\u2019immunit\u00e9 collective - Asialyst","isPartOf":{"@id":"https:\/\/asialyst.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/asialyst.com\/fr\/2021\/07\/30\/covid-19-chine-incertitudes-immunite-collective\/#primaryimage"},"image":{"@id":"https:\/\/asialyst.com\/fr\/2021\/07\/30\/covid-19-chine-incertitudes-immunite-collective\/#primaryimage"},"thumbnailUrl":"https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/07\/chine-vaccination-immunite-collective.jpg","datePublished":"2021-07-30T05:28:52+00:00","dateModified":"2021-07-30T15:07:44+00:00","breadcrumb":{"@id":"https:\/\/asialyst.com\/fr\/2021\/07\/30\/covid-19-chine-incertitudes-immunite-collective\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/asialyst.com\/fr\/2021\/07\/30\/covid-19-chine-incertitudes-immunite-collective\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/asialyst.com\/fr\/2021\/07\/30\/covid-19-chine-incertitudes-immunite-collective\/#primaryimage","url":"https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/07\/chine-vaccination-immunite-collective.jpg","contentUrl":"https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2021\/07\/chine-vaccination-immunite-collective.jpg","width":1200,"height":900,"caption":"Vaccination de lyc\u00e9ens dans le district de Qianjiang \u00e0 Chongqing. Photograph: Sipa Asia\/Rex\/Shutterstock (Source : Guardian)"},{"@type":"BreadcrumbList","@id":"https:\/\/asialyst.com\/fr\/2021\/07\/30\/covid-19-chine-incertitudes-immunite-collective\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/asialyst.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Covid-19 en Chine : les incertitudes de l\u2019immunit\u00e9 collective"}]},{"@type":"WebSite","@id":"https:\/\/asialyst.com\/fr\/#website","url":"https:\/\/asialyst.com\/fr\/","name":"Asialyst","description":"Votre m\u00e9dia sur l Asie","publisher":{"@id":"https:\/\/asialyst.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/asialyst.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/asialyst.com\/fr\/#organization","name":"Asialyst","url":"https:\/\/asialyst.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/asialyst.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2015\/04\/logo_blanc.png","contentUrl":"https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2015\/04\/logo_blanc.png","width":657,"height":165,"caption":"Asialyst"},"image":{"@id":"https:\/\/asialyst.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Asialyst.fr"]},{"@type":"Person","@id":"https:\/\/asialyst.com\/fr\/#\/schema\/person\/69bfaa6a2bbb4d14c7f57c078c1b94cb","name":"Hubert Testard","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2022\/12\/hubert-testard-137x150.jpg","url":"https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2022\/12\/hubert-testard-137x150.jpg","contentUrl":"https:\/\/asialyst.com\/fr\/wp-content\/uploads\/2022\/12\/hubert-testard-137x150.jpg","caption":"Hubert Testard"},"description":"Hubert Testard est un sp\u00e9cialiste de l\u2019Asie et des enjeux \u00e9conomiques internationaux. Il a \u00e9t\u00e9 conseiller \u00e9conomique et financier pendant 20 ans dans les ambassades de France au Japon, en Chine, en Cor\u00e9e et \u00e0 Singapour pour l\u2019Asean. Il a \u00e9galement particip\u00e9 \u00e0 l\u2019\u00e9laboration des politiques europ\u00e9ennes et en particulier de la politique commerciale, qu\u2019il s\u2019agisse de l\u2019OMC ou des n\u00e9gociations avec les pays d\u2019Asie. Il enseigne depuis onze ans au coll\u00e8ge des affaires internationales de Sciences Po sur l\u2019analyse prospective de l\u2019Asie. Il est l\u2019auteur d\u2019un livre intitul\u00e9 \"Pand\u00e9mie, le basculement du monde\", paru en mars 2021 aux \u00e9ditions de l\u2019Aube, et il a contribu\u00e9 en octobre 2022 \u00e0 un ouvrage collectif intitul\u00e9 \"Le dossier chinois\" aux \u00e9ditions Le Cherche-Midi.","url":"https:\/\/asialyst.com\/fr\/auteur\/hubert-testard\/"}]}},"_links":{"self":[{"href":"https:\/\/asialyst.com\/fr\/wp-json\/wp\/v2\/posts\/53052","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/asialyst.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/asialyst.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/asialyst.com\/fr\/wp-json\/wp\/v2\/users\/277"}],"replies":[{"embeddable":true,"href":"https:\/\/asialyst.com\/fr\/wp-json\/wp\/v2\/comments?post=53052"}],"version-history":[{"count":4,"href":"https:\/\/asialyst.com\/fr\/wp-json\/wp\/v2\/posts\/53052\/revisions"}],"predecessor-version":[{"id":53053,"href":"https:\/\/asialyst.com\/fr\/wp-json\/wp\/v2\/posts\/53052\/revisions\/53053"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/asialyst.com\/fr\/wp-json\/wp\/v2\/media\/53057"}],"wp:attachment":[{"href":"https:\/\/asialyst.com\/fr\/wp-json\/wp\/v2\/media?parent=53052"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/asialyst.com\/fr\/wp-json\/wp\/v2\/categories?post=53052"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/asialyst.com\/fr\/wp-json\/wp\/v2\/tags?post=53052"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}